Here's What to Expect From Pfizer's Non-Oncology Drugs in Q2 Earnings
Pfizer boasts a strong presence in other areas like internal medicine, vaccines, inflammation & immunology and rare disease, among others. Other than the Oncology segment, it operates through the Primary Care and Specialty Care segments. Let's discuss how the drugs in these two non-oncology segments are expected to perform in the second quarter.
In Primary Care, alliance revenues and direct sales from Bristol-Myers BMY -partnered Eliquis are likely to have declined due to Inflation Reduction Act or IRA-driven lower pricing, which will partially offset the benefit from higher demand. Sales of key vaccine Prevnar are also expected to have declined due to lower sales in international markets.
Pfizer records direct sales and alliance revenues from its partner, BioNTech BNTX, for its COVID-19 vaccine, Comirnaty. Revenues from Pfizer/BioNTech's COVID vaccine, Comirnaty, rose in the first quarter due to higher revenues in the United States (due to lower expected returns and higher market share) and higher contractual deliveries in some ex-U.S. markets. It remains to be seen if the improved trend continued in the second quarter of 2025.
However, sales of its antiviral pill for COVID, Paxlovid, are likely to have declined due to lower infection rates.
Among the newer products, while sales of Nurtec ODT/Vydura are likely to have risen, those of RSV vaccine, Abrysvo, are expected to have continued to decline due to limited recommendations for RSV vaccinations issued by the US Advisory Committee on Immunization Practices.
In the Specialty Care unit, while sales of Vyndaqel are likely to have remained strong, driven by continued demand growth, sales of Xeljanz and Enbrel are likely to have declined.
PFE's Price Performance, Valuation and Estimates
Pfizer's stock has declined 1.8% so far this year compared with a decrease of 1.3% for the industry.
From a valuation standpoint, Pfizer appears attractive relative to the industry and is trading below its 5-year mean. Going by the price/earnings ratio, the company's shares currently trade at 8.20 forward earnings, lower than 14.60 for the industry and the stock's 5-year mean of 10.85.
The Zacks Consensus Estimate for 2025 earnings has declined from $3.06 per share to $3.05 per share, while that for 2026 has gone down from $3.09 to $3.08 per share over the past 60 days.
Pfizer has a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Bristol Myers Squibb Company (BMY): Free Stock Analysis Report
Pfizer Inc. (PFE): Free Stock Analysis Report
BioNTech SE Sponsored ADR (BNTX): Free Stock Analysis Report
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
24 minutes ago
- Globe and Mail
Hilton Grand (HGV) Q2 Revenue Misses 8%
Key Points GAAP revenue was $1.266 billion for Q2 2025, missing analyst expectations by $111.6 million. Adjusted EPS (non-GAAP) was $0.54, falling short of estimates, compared to an expected $0.81 (non-GAAP). Contract sales increased 10.2% to $834 million, but adjusted free cash flow dropped sharply. These 10 stocks could mint the next wave of millionaires › Hilton Grand Vacations (NYSE:HGV), a leading timeshare and vacation ownership company behind the Hilton brand, reported Q2 2025 results on July 31, 2025. The release highlighted strong contract sales and ongoing integration of acquired businesses, particularly Bluegreen Vacations. However, both GAAP revenue and non-GAAP adjusted earnings per share missed Wall Street forecasts. GAAP revenue reached $1.266 billion versus estimates of $1.378 billion, and adjusted EPS (non-GAAP) was $0.54 compared to an expected $0.81. The period saw solid top-line growth in contract sales and notable operational gains, but also margin pressure, a significant drop in adjusted free cash flow (non-GAAP), and weak membership growth, with consolidated Net Owner Growth (NOG) of 0.6% for the twelve months ended Q2 2025. Metric Q2 2025 Q2 2025 Estimate Q2 2024 Y/Y Change Adjusted EPS (Non-GAAP) $0.54 $0.81 $0.62 (12.9 %) Revenue (GAAP) N/A N/A $1.24 billion N/A Adjusted EBITDA Attributable to Stockholders $233 million $262 million (11.1 %) Contract Sales $834 million $757 million 10.2 % Adjusted Free Cash Flow $135 million $370 million (63.5 %) Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Business Overview and Strategic Focus Hilton Grand Vacations focuses on selling vacation ownership interests (VOIs), commonly known as timeshares, across the United States and internationally. Its business includes real estate sales, resort operations, club management, rental and ancillary services, and a lending arm that provides financing for timeshare buyers. The company leverages the well-known Hilton brand and a network of partnerships, including those with Bass Pro Shops and Choice Hotels, to attract and serve customers. Recently, the company's strategy has emphasized expansion through acquisitions and brand partnerships. The purchase of Bluegreen Vacations in January 2024 broadened the product range and increased the customer base. Success depends on effective integration of these acquisitions, leveraging brand recognition, strong inventory management, and maintaining robust financing solutions for customers. Key performance measures include contract sales, membership growth, and profitability margins across its business segments. Key Developments and Metrics for the Quarter Contract sales rose 10.2% to $834 million in Q2 2025. Despite higher headline sales, overall GAAP revenue and adjusted EPS (non-GAAP) both came in below analyst estimates. The real estate sales and financing segment posted $760 million in revenue, but profit margins experienced pressure in part from a $45 million net deferral tied to ongoing projects in Hawaii and Japan. Financing revenue benefited from higher interest rates and a larger loan portfolio, with segment financing revenue up $24 million compared to Q2 2024 and profit margin (non-GAAP) remained relatively stable. The timeshare financing loan book totaled approximately $4.02 billion as of December 31, 2024, maintaining a 15.0% weighted average interest rate as of December 31, 2024 with a 10.2% annualized default rate for Q1 2025. In resort operations and club management, revenue grew by $19 million to $405 million, yet adjusted EBITDA slipped from $152 million to $149 million, and Adjusted EBITDA profit margin dropped to 36.8%. Club membership was approximately 724,300 as of Q2 2025, with net owner growth at just 0.6% over the trailing twelve months ended June 30, 2025, compared to 1.7% in the prior twelve months. The rental and ancillary services segment, which covers services beyond core timeshare sales, reported $195 million in GAAP revenue (flat year over year). This segment moved to a loss of $8 million from a $7 million profit compared to Q2 2024, with the profit margin falling to negative 4.1% (non-GAAP). Long-Term Positioning, Acquisition, and Financial Actions Rebranding projects and the expansion of the HGV Max member platform continued, leveraging acquired customer bases and locations. These actions are designed to boost operating efficiencies and drive customer engagement across the expanded resort portfolio. Inventory management continues to be crucial, with the company's pipeline valued at $13.3 billion based on current prices as of Q2 2025. Owned inventory represented 90.6% of the company's total contract sales pipeline as of Q2 2025, and fee-for-service inventory -- where the company manages but does not own vacation units -- has dropped as a share of the mix. This strategy places more risk on the balance sheet if sales slow, so maintaining sales momentum is key. On the financial services front, the company's lending operations contributed significantly to revenue and profit, with most loans carrying interest rates around 15.0% as of December 31, 2024. Securitization of its loan book remains a core liquidity strategy, allowing HGV to convert loan assets into cash that it can use for both operational needs and shareholder returns. Shareholder returns were highlighted by share repurchases: 4.1 million shares were repurchased for $150 million in Q2 2025. The board approved an additional $600 million repurchase authorization over a two-year period on July 29, 2025. Cash flow, however, faced pressure. Adjusted free cash flow dropped 63.5% year over year in Q2 2025. Free cash flow was $28 million, compared to $95 million for the same period in the prior year, a 70.5% decline. The company's net leverage ratio remained at approximately 3.9x trailing-twelve-month EBITDA as of June 30, 2025. Hilton Grand Vacations does not currently pay a dividend. Outlook and What to Watch Ahead Management reiterated its prior 2025 guidance for full-year adjusted EBITDA (before deferrals and recognitions), holding the range at $1.125 billion to $1.165 billion. No additional or updated guidance was provided for revenue or earnings per share for the remainder of the year. For investors and observers, membership growth, the pace of Bluegreen integration, and recovery in profit margins are watch points for the next periods. Potential risks include further pressure on cash flow, slower net owner growth, and the impacts of greater reliance on owned (rather than fee-for-service) inventory. The company also flagged ongoing macroeconomic risks that could affect consumer demand, but refrained from offering new quantitative outlooks beyond the EBITDA guidance. Revenue and net income presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted. Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,036%* — a market-crushing outperformance compared to 181% for the S&P 500. They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor. See the stocks » *Stock Advisor returns as of July 29, 2025
Globe and Mail
24 minutes ago
- Globe and Mail
Apple Inc. Reports Record-Breaking Q3 2025 Earnings
Apple Inc ( (AAPL)) has released its Q3 earnings. Here is a breakdown of the information Apple Inc presented to its investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Apple Inc., a leading technology company renowned for its innovative products and services, operates primarily in the consumer electronics and software industry. Known for its flagship products like the iPhone, iPad, and Mac, Apple continues to set benchmarks in the tech world with its seamless ecosystem of devices and services. In its fiscal 2025 third quarter earnings report, Apple announced a record-breaking performance with a total revenue of $94 billion, marking a 10% increase from the previous year. The company also reported a significant rise in its earnings per share, which grew by 12% to $1.57. This quarter was highlighted by strong growth in iPhone, Mac, and Services revenue, alongside a global expansion in all geographic segments. Key financial metrics revealed a robust performance, with Apple's net income reaching $23.4 billion, up from $21.4 billion in the same quarter last year. The company's services sector hit a new all-time high, contributing $27.4 billion to the total revenue. Additionally, Apple's installed base of active devices achieved a new peak, driven by high customer satisfaction and loyalty. Apple's strategic announcements included the introduction of a new software design across all platforms and enhanced Apple Intelligence features, unveiled during the WWDC25. The board of directors declared a cash dividend of $0.26 per share, reinforcing Apple's commitment to returning value to its shareholders. Looking ahead, Apple remains optimistic about its future growth, focusing on innovation and customer satisfaction. The company's management continues to navigate the competitive tech landscape with strategic investments in product development and market expansion.
CTV News
an hour ago
- CTV News
CTV National News: Trump fires senior official over jobs numbers
CTV National News: Trump fires senior official over jobs numbers U.S. President Donald Trump has ordered the firing of the head of the Bureau of Labor Statistics after job numbers were lower than expected in July.
